Commonwealth Equity Services’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
VCM
LG
Commonwealth Equity Services's CLPT Position: Q1 2026 in Review
Commonwealth Equity Services increased its ClearPoint Neuro (CLPT) stake by 9% in Q1 2026, buying an estimated $74.4K and bringing the position to 71,448 shares worth $650K. The position accounts for ﹤0.01% of the portfolio, ranked #2981.
Commonwealth Equity Services first reported a position in CLPT in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.4M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.
- Commonwealth Equity Services held 71,448 shares of ClearPoint Neuro worth $650K as of Q1 2026.
- Commonwealth Equity Services bought 5,891 ClearPoint Neuro shares in Q1 2026, an estimated $74.4K.
- ClearPoint Neuro made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #2981 holding.
- Commonwealth Equity Services first reported a position in ClearPoint Neuro in Q3 2021 and has held it in 19 quarters since.
- Commonwealth Equity Services's ClearPoint Neuro position peaked at $1.4M in Q3 2025.
- 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.